Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zum Wirkstoff Bimekizumab
AOK Baden-Württemberg Hauptverwaltung awarded €221K to UCB GmbH for Healthcare & Medical in December 2024 — one of 299 awards this buyer has made, in line with its typical award size.
Buying agency
AOK Baden-Württemberg HauptverwaltungWinning supplier
UCB GmbHContract description
Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zum Wirkstoff Bimekizumab
Related awards · AOK Baden-Württemberg Hauptverwaltung
299 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-761135-2024enercity AG€1.8M12 Dec 2024 Energy
- ocds-ted-223384-2025Blocher GmbH / blocher partners€1.5M07 Apr 2025 Professional Services
- ocds-ted-220707-2025IBK Ingenieurbüro Kaya GmbH€744K07 Apr 2025 Professional Services
Other wins · UCB GmbH
4 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-412645-2025AOK Baden-Württemberg Hauptverwaltung€221K26 Jun 2025 Healthcare
- ocds-ted-346803-2024GWQ ServicePlus AG€112 Jun 2024 Healthcare
- ocds-ted-860003-2025GWQ ServicePlus AG€124 Dec 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for AOK Baden-Württemberg Hauptverwaltung and UCB GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back